Cargando…

Effectiveness of anti-TNF-α agents in the treatment of refractory juvenile dermatomyositis

Detalles Bibliográficos
Autores principales:	Boulter, EL, Beard, L, Ryder, C, Pilkington, CA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194424/ http://dx.doi.org/10.1186/1546-0096-9-S1-O29

Ejemplares similares

Sub-phenotyping of juvenile dermatomyositis: can it assist clinical decisions?
por: Yasin, Shireena A, et al.
Publicado: (2014)

Treatment of refractory juvenile dermatomyositis with tacrolimus
por: Hassan, J, et al.
Publicado: (2008)

Toll-like receptor 2 polymorphism in juvenile dermatomyositis
por: Mathiesen, P, et al.
Publicado: (2011)

PReS-FINAL-2130-A: Effectiveness of intravenous cyclophosphamide in severe or refractory juvenile dermatomyositis - a national cohort study UK and Ireland
por: Moraitis, E, et al.
Publicado: (2013)

8.5 Predictors of long-term outcome of Juvenile Dermatomyositis (JDM): a Multicenter, Multinational Study of 490 patients
por: Ferrari, C, et al.
Publicado: (2008)

Proposal for the development of an international minimal data collection for juvenile dermatomyositis (JDM)
por: McCann, Liza J, et al.
Publicado: (2011)

PReS-FINAL-2193: Assessment of construct validity of new measures of global disease activity, physical function and quality of life in children with juvenile dermatomyositis
por: Ferrari, C, et al.
Publicado: (2013)

3.5 Comparison of functional ability in juvenile idiopathic arthritis, juvenile dermatomyositis, juvenile systemic lupus erythematosus and healthy controls. An analysis of the PRINTO database
por: Filocamo, G, et al.
Publicado: (2008)

Comparison of data from the juvenile dermatomyositis national (UK & Ireland) cohort biomarker study and repository for idiopathic inflammatory myopathies with a survey of current practice throughout the UK and Ireland
por: Martin, N, et al.
Publicado: (2011)

What is the mortality of Juvenile Dermatomyositis (JDM) in the modern treatment era
por: Smith, S, et al.
Publicado: (2008)

Dyslipidemia in active juvenile dermatomyositis patients
por: Kozu, KT, et al.
Publicado: (2011)

CD4(+)FOXP3(+) regulatory T cells are abundantly present in inflamed muscle of patients with juvenile dermatomyositis
por: Vercoulen, Yvonne, et al.
Publicado: (2011)

PReS-FINAL-1020: Dysregulation of the peripheral blood D cell compartment is associated with disease activity in juvenile dermatomyositis
por: Piper, C, et al.
Publicado: (2013)

Reverse signalling of membrane TNF in human natural killer cells: a comparison of the effect of certolizumab pegol and other anti-TNF agents
por: Fossati, Gianluca, et al.
Publicado: (2011)

Treatment of calcinosis with biphosphonates in juvenile dermatomyositis
por: Bilginer, Y, et al.
Publicado: (2008)

PReS-FINAL-2012: Introducing a new approach to clinical care of juvenile dermatomyositis: the juvenile dermatomyositis multidimensional assessment report
por: Varnier, GC, et al.
Publicado: (2013)

The PRINTO provisional definition of remission in juvenile dermatomyositis
por: Lazarevic, D, et al.
Publicado: (2011)

8.4 Novel autoantibodies targeting a p140 protein are a major autoantigen system in juvenile dermatomyositis and a marker of calcinosis
por: Gunawardena, H, et al.
Publicado: (2008)

OA29 Blotting-based assays under-detected TIF1-gamma and NXP2 autoantibodies compared to immunoprecipitation in Juvenile Dermatomyositis cohorts
por: Nguyen, Huong D, et al.
Publicado: (2022)

New mechanisms of action and signaling by TNF-α
por: Ivashkiv, Lionel B
Publicado: (2012)

12. Dramatic improvement of chronic pleural effusion with abatacept treatment in longstanding rheumatoid arthritis, after chest sepsis during treatment with anti-TNF-α
por: McKee, Natalie, et al.
Publicado: (2019)

OA16 A case of anti-MDA5 dermatomyositis: the challenge of atypical skin manifestations
por: Biddle, Kathryn, et al.
Publicado: (2023)

4. A paraneoplastic case of dermatomyositis
por: Wilson-Morkeh, Harold, et al.
Publicado: (2019)

Juvenile dermatomyositis in Western Switzerland
por: Enders, F Bellutti, et al.
Publicado: (2011)

Thrombotic microangiopathy in juvenile dermatomyositis
por: Frolenko, A, et al.
Publicado: (2011)

PReS-FINAL-2184: A randomized trial in new onset juvenile dermatomyositis: prednisone versus prednisone plus cyclosporine versus prednisone plus methotrexate
por: Ruperto, N, et al.
Publicado: (2013)

Gastroparesis associated with Juvenile Dermatomyositis
por: Martin, N, et al.
Publicado: (2008)

Respiratory involvement in juvenile dermatomyositis
por: Fabi, M, et al.
Publicado: (2008)

Comparison of Children With Onset of Juvenile Dermatomyositis Symptoms Before or After Their Fifth Birthday in a UK and Ireland Juvenile Dermatomyositis Cohort Study
por: Martin, N, et al.
Publicado: (2012)

Tubuloreticular inclusions in juvenile dermatomyositis: a diagnostically useful marker?
por: Yasin, Shireena A, et al.
Publicado: (2014)

2. Two cases of anti-MDA5 positive dermatomyositis with rapidly progressive interstitial lung disease
por: Levasseur, Kirsty, et al.
Publicado: (2019)

Rapid and sustained effect of anti-TNF treatment in patients with ADA2 deficiency
por: Caorsi, R, et al.
Publicado: (2015)

Differences in therapeutic approach to juvenile dermatomyositis between Europe and Latin America
por: Trail, L, et al.
Publicado: (2008)

SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile dermatomyositis
por: Enders, Felicitas Bellutti, et al.
Publicado: (2014)

Clinically inactive disease in juvenile dermatomyositis – a proposed revision to the printo criteria
por: Almeida, Beverley, et al.
Publicado: (2014)

Juvenile dermatomyositis (JDM) sine myositis
por: Schuetz, C, et al.
Publicado: (2011)

Subclinical pulmonary abnormalities in juvenile dermatomyositis
por: Sallum, Adriana M, et al.
Publicado: (2014)

Synovial fibroblasts display an uncontrolled inflammatory and tissue destructive response to TNF-α
por: Kalliolias, George D, et al.
Publicado: (2012)

Evaluation of the cardiovascular system in patients with juvenile dermatomyositis
por: Opoka – Winiarska, Violetta, et al.
Publicado: (2011)

Calcinosis as a complication of juvenile dermatomyositis (JDM)
por: Clara, Malagón, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4al38b8a62bsbv3lp7as0st607